Oestra® and Endometriosis: How Our Approach Is Different

Endometriosis affects millions of women and can cause symptoms such as pelvic pain, painful periods, bloating, fatigue, painful intercourse, and inflammation throughout the body.
​
Many women are surprised to learn that hormone therapy is not one-size-fits-all when it comes to endometriosis. The way hormones are delivered can significantly impact how the body responds.
​

Yes.
Many women in our community have endometriosis, and Oestra™ was specifically designed with hormone balance and inflammation reduction in mind.
Our goal is not simply to mask symptoms, but to address underlying hormonal imbalances that may contribute to inflammation, discomfort, and poor quality of life.
​

Traditional approaches to endometriosis often involve:
​

While these approaches may be appropriate in certain situations, they do not work for everyone.
Oestra™ takes a different approach by utilizing vaginal delivery of bioidentical hormones.
This route allows progesterone to reach the uterus first, where it can be converted into an important metabolite called DHP (Dihydroprogesterone).
​

DHP is a natural metabolite produced when progesterone is delivered directly to uterine tissues.
Many researchers believe DHP plays an important role in progesterone's therapeutic effects because it:
​

For many women with endometriosis, DHP may be one of the most important downstream effects of progesterone therapy.
​

When progesterone is taken orally, much of it is processed through the liver before reaching target tissues.
With vaginal delivery, progesterone reaches the reproductive tissues more directly, allowing for greater local exposure and increased DHP production.
This unique delivery method is one of the key reasons Oestra™ differs from many traditional hormone therapies.
​

One of the most common concerns women have is whether hormone therapy will stimulate endometrial tissue growth.
Oestra™ was formulated to support hormone balance while prioritizing progesterone's protective and anti-inflammatory effects.
Rather than simply adding estrogen, Oestra™ combines bioidentical hormones in a way designed to support overall balance and help calm inflammatory signaling that may contribute to endometriosis symptoms.
​

Even after ovary removal, hormones continue to play an important role throughout the body.
Balanced estrogen and progesterone support may affect:
​

For this reason, many women continue to benefit from thoughtful hormone support even after surgical menopause.
​

Endometriosis can present differently from one woman to another, and factors such as prior surgeries, ovarian status, symptom severity, and medical history all influence treatment decisions.
While Oestra™ was designed with hormone balance and inflammation reduction in mind, the best approach is always individualized.
Once you become a client, our clinical team can review your personal health history and help determine whether Oestra™ is an appropriate fit for your specific situation.
​

Oestra™ was developed with a unique hormone delivery approach that supports progesterone's conversion to DHP, a powerful metabolite associated with anti-inflammatory and progesterone-supportive effects.
Unlike approaches that focus solely on symptom suppression, Oestra™ is designed to promote hormone balance while helping support healthy inflammatory responses that may contribute to endometriosis symptoms.
If you have endometriosis and are exploring hormone therapy options, our clinical team can help determine the approach that best aligns with your health goals.
​

The goal is not to eliminate these foods but to eat them in moderation and understand how they could be impacting the benefit you recieve from your HRT.
​